Literature DB >> 6446471

Arthrogryposis multiplex congenita due to congenital myasthenia.

L M Smit, P G Barth.   

Abstract

Decreased fetal movements may cause arthrogryposis multiplex congenita. Several distinct neuromuscular disorders may cause this syndrome, but congenital myasthenia has not previously been considered to be a possible cause. The authors report a case of congenital myasthenia gravis leading to arthrogryposis congenita.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6446471     DOI： 10.1111/j.1469-8749.1980.tb03718.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN： 0012-1622            Impact factor:   5.449


  5 in total

1.  Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita.

Authors:  S Brownlow; R Webster; R Croxen; M Brydson; B Neville; J P Lin; A Vincent; J Newsom-Davis; D Beeson
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans.

Authors:  K Ohno; A Tsujino; J M Brengman; C M Harper; Z Bajzer; B Udd; R Beyring; S Robb; F J Kirkham; A G Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

3.  A case of congenital bilateral absence of elbow flexor muscles: review of differential diagnosis and treatment.

Authors:  David T Netscher; Oluseyi Aliu; Saleh Samra; Eric Lewis
Journal:  Hand (N Y)       Date:  2007-10-09

4.  Paucity of secondary synaptic clefts in a case of congenital myasthenia with multiple contractures: ultrastructural morphology of a developmental disorder.

Authors:  L M Smit; F G Jennekens; H Veldman; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-10       Impact factor: 10.154

5.  Familial infantile myasthenia: a neuromuscular cause of respiratory failure.

Authors:  E Zammarchi; M A Donati; S Masi; A Sarti; S Castelli
Journal:  Childs Nerv Syst       Date:  1994-07       Impact factor: 1.475
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.